X

Marksans Pharma Ltd Q1FY24; 17% rise in Profits

Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products.

Financial Results:

Marksans Pharma Ltd reported Revenues for Q1FY24 of ₹500.00 Crores up from ₹434.00 Crore year on year, a rise of 15.21%.

Total Expenses for Q1FY24 of ₹414.00 Crores up from ₹374.00 Crores year on year, a rise of 10.7%.

Consolidated Net Profit of ₹70.00 Crores up 16.67% from ₹60.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹1.52, up 4.11% from ₹1.46 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post